Industry Updates

Modern pharmaceutical manufacturing requires a shift from reactive problem-solving to proactive risk mitigation through structured frameworks that ensure patient safety and product efficacy across the global supply chain.

The strategic application of performance indicators allows healthcare leaders to move beyond intuitive management, leveraging objective data to enhance patient outcomes and operational sustainability across complex medical institutions.

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Tempus and NYU Langone Health have signed a multi-year strategic collaboration to drive precision oncology using molecular profiling and data-driven research. The Tempus-NYU Langone collaboration...

Natera has announced a collaboration with NVIDIA to drive the adoption of AI foundation models across the spectrum of precision medicine. The Natera-NVIDIA AI collaboration...

W.L. Gore & Associates, the global materials science company, has gone on to reach an agreement to go ahead and acquire Conformal Medical, which is...